Evidence map›Paper›PMID 37524740›Full record

ArticleNPJ genomic medicine2023

Scaling-up and future sustainability of a national reproductive genetic carrier screening program.

Zoe Fehlberg, Stephanie Best, Janet C Long, Tahlia Theodorou, Catherine Pope, Peter Hibbert, Sharon Williams, Lucinda Freeman, Sarah Righetti, Alison D Archibald and 1 more

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zoe FehlbergAustralian Institute of Heath Innovation, Macquarie University, Sydney, Australia.ORCID http://orcid.org/0000-0002-8449-206X
Stephanie BestAustralian Institute of Heath Innovation, Macquarie University, Sydney, Australia. stephanie.best@petermac.org.ORCID http://orcid.org/0000-0002-1107-8976
Janet C LongAustralian Institute of Heath Innovation, Macquarie University, Sydney, Australia.
Tahlia TheodorouAustralian Institute of Heath Innovation, Macquarie University, Sydney, Australia.
Catherine PopeNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Peter HibbertAustralian Institute of Heath Innovation, Macquarie University, Sydney, Australia.
Sharon WilliamsSchool of Health & Social Care, Swansea University, Swansea, Wales, UK.
Lucinda FreemanSchool of Women's and Children's Health, University of New South Wales, Sydney, Australia.
Sarah RighettiSchool of Women's and Children's Health, University of New South Wales, Sydney, Australia.
Alison D ArchibaldVictorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.
Jeffrey BraithwaiteAustralian Institute of Heath Innovation, Macquarie University, Sydney, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An understanding of factors influencing implementation is essential to realise the benefits of population-based reproductive genetic carrier screening programs. The aim of this study was to synthesise data collected during the Australian Reproductive Genetic Carrier Screening Project (Mackenzie's Mission) to track how priorities shifted over time and identify important factors during scaling-up and for sustainment. We used a multi-method qualitative approach to integrate longitudinal project data collected from 10 project committees with 16 semi-structured interviews conducted with study team members. Both datasets were analysed using the Consolidated Framework for Implementation Research (CFIR) to identify constructs of interest within early, mid-point, and future implementation phases. Several CFIR constructs were present across implementation. The complexity of implementation presented challenges that were overcome through a quality-designed and packaged product, formal and informal networks and communication, and access to knowledge and information. Addressing the diverse consumer needs through resources and increasing community and non-genetic speciality engagement remained a priority throughout and for future sustainment. Going forward, further addressing program complexities and securing funding were emphasised. By applying an implementation framework, findings from this study may be useful for future effort towards building and/or sustaining reproductive genetic carrier screening programs.

Identifiers

PMID37524740
PMCPMC10390466

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.